Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

RenovoRx, Inc. (RNXT)

1.0550
+0.0250
+(2.43%)
At close: May 7 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
43
43
0
0
0
Cost of Revenue
0
0
0
--
--
Gross Profit
43
43
0
--
--
Operating Expense
11,013
11,013
11,396
9,950
5,671
Operating Income
-10,970
-10,970
-11,396
-9,950
-5,671
Net Non Operating Interest Income Expense
384
384
-545
57
-834
Other Income Expense
1,772
1,772
1,709
4
181
Pretax Income
-8,814
-8,814
-10,232
-9,889
-6,324
Net Income Common Stockholders
-8,814
-8,814
-10,232
-9,889
-6,324
Diluted NI Available to Com Stockholders
-8,814
-8,814
-10,232
-9,889
-6,324
Basic EPS
-0.40
--
-0.99
-1.09
-1.21
Diluted EPS
-0.40
--
-0.99
-1.09
-1.21
Basic Average Shares
22,271.1630
--
10,290.6670
9,051.7260
5,217
Diluted Average Shares
22,271.1630
--
10,290.6670
9,051.7260
5,217
Total Operating Income as Reported
-10,970
-10,970
-11,396
-9,950
-5,671
Total Expenses
11,013
11,013
11,396
9,950
5,671
Net Income from Continuing & Discontinued Operation
-8,814
-8,814
-10,232
-9,889
-6,324
Normalized Income
-10,586
-10,586
-11,941
-9,889
-6,386
Interest Income
--
--
--
57
--
Interest Expense
--
--
--
--
834
Net Interest Income
384
384
-545
57
-834
EBIT
-10,970
-10,970
-11,396
-9,950
-5,490
EBITDA
-10,970
-10,970
-11,396
-9,944
-5,481
Reconciled Cost of Revenue
0
0
0
--
--
Reconciled Depreciation
10
--
0
6
9
Net Income from Continuing Operation Net Minority Interest
-8,814
-8,814
-10,232
-9,889
-6,324
Total Unusual Items Excluding Goodwill
1,772
1,772
1,709
0
62
Total Unusual Items
1,772
1,772
1,709
0
62
Normalized EBITDA
-12,742
-12,742
-13,105
-9,944
-5,543
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/26/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACTU Actuate Therapeutics, Inc. Common stock
9.30
+0.98%
 
INDP Indaptus Therapeutics, Inc.
0.4300
0.00%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
PRLD Prelude Therapeutics Incorporated
0.7643
-3.98%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.1700
-0.85%
 
INAB IN8bio, Inc.
0.1645
+0.43%
 
ABVC ABVC BioPharma, Inc.
1.2700
+10.43%
 
PALI Palisade Bio, Inc.
0.7600
-8.96%
 
PBLA Panbela Therapeutics, Inc.
0.3150
0.00%
 
ENTA Enanta Pharmaceuticals, Inc.
5.06
+0.20%